- While many capitalization structures are diluted in the landscape of over-the-counter (“OTC”) markets, Earth Science Tech is doing the opposite, as the management team owns over 47% of the shares
- This high level of insider ownership is significant, as it shows the leadership strongly believes in the company, and have financial outcomes tied closely to the stock’s performance
- As a result, this greatly reduces the risk that management benefits while investors don’t, as management is financially aligned with outside investors
In many over-the-counter (“OTC”) markets, capitalization structures are often diluted, and the incentives of management are misaligned, which may leave leadership unmotivated. However, Earth Science Tech (OTC: ETST), a strategic holding company, flips this idea on its head.
While the company’s robust Q2 revenue growth of $17.8 million in H1 Fiscal 2026, as well as its pivot to SIC Code 2834 (Pharmaceutical Preparations) have made headlines, a more subtle and significant…
NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at https://ibn.fm/ETST
About BioMedWire
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer
BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is powered by IBN
